Early detection of multiple sclerosis (MS) is critical for treating to preserve brain tissue, yet most patients are diagnosed years after symptoms begin, and therapeutic options for the progressive stage of disease are limited.
Read how Professor Maja Jagodic of the Karolinska Institutet and her team are combining genomic and epigenomic analyses to uncover how genetics, environment, and lifestyle interact in the onset and progression of MS
